THERAMetrics : SIX: TMX) announces today that it has completed the acquisition of 38,500,000 of its own shares from its shareholders Pierrel S.p.A. and Fin Posillipo S.p.A.

Stans, Switzerland, August 03, 2015

THERAMetrics holding AG (the Company) announces today that it has completed the re-purchase of 38,500,000 of its own shares from its shareholders Pierrel S.p.A. and Fin Posillipo S.p.A.

The re-purchase, for a total symbolic consideration of CHF 1.00, was made pursuant to the combination agreement of January 24, 2013 by and between the Company (formerly mondoBIOTECH holding AG) on one hand and Pierrel S.p.A. and Fin Posillipo S.p.A. on the other hand. At the closing of the business combination between mondoBIOTECH holding AG and Pierrel Research International AG, in September 2013, Pierrel S.p.A. and Fin Posillipo S.p.A. had been given 2.75 shares of the Company for each share held by the old mondoBIOTECH holding AG shareholders, on a fully diluted basis (i.e. assuming the exercise of pre-existing option and conversion rights, and in particular 14 million warrants of investor Global Emerging Market (GEM). Since GEM did not exercise any of its warrants and these have meanwhile lapsed, pursuant to the combination agreement the Company had the right to re-purchase the 2.75-fold number of own shares, i.e. 38,500,000, for a symbolic price, which right it has now exercised.

Of the 38,500,000 shares, 29,348,550 shares have been purchased from Pierrel S.p.A. and 9,151,450 have been purchased from Fin Posillipo S.p.A.

After the transaction, Pierrel S.p.A. owns 27% of the Company's shares, and Fin Posillipo S.p.A. owns 31%. They remain the Company's two largest shareholders.

About Therametrics holding AG
Therametrics holding AG is a global tech-based Contract Research & Development Organisation dedicated to providing a full range of technological solutions through the entire value chain of drug discovery and development. The company is listed on the SIX Swiss Exchange under the symbol TMX and is headquartered in Stans, Switzerland.

For further information please contact
Raffaele Petrone
THERAMetrics holding AG
Investor and External Relations
T. +41 (0)44 723 59 59
F. +41 (0)44 726 90 12
investor@therametrics.com
www.therametrics.com

Media relation:
Press Area - Società & Servizi srl
mi@areacomunicazione.info

Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning THERAMetrics holding AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of THERAMetrics holding AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. THERAMetrics holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.